+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhaled corticosteroids may be superior to systemic corticosteroids in children with moderate-to-severe acute asthma



Inhaled corticosteroids may be superior to systemic corticosteroids in children with moderate-to-severe acute asthma



Pediatric Asthma Allergy & Immunology 16(3): 121-128, Fall



The objective of this study was to assess the efficacy of inhaled triamcinalone as compared to oral prednisone or intravenous methylprednisolone in the treatment of children with moderate-to-severe acute asthma. This prospective, randomized trial involved convenience sampling of children 6 years and older presenting to one of two pediatric emergency centers. Patients were randomized to receive inhaled, oral, or intravenous corticosteroids. Patients receiving inhaled corticosteroids (600 mcg of inhaled triamcinalone acetonide with inhaler and spacer) in the emergency center and discharged home, received 4 consecutive days of the same preparation (600 mcg TID for 1 day and 400 mcg TID for the next 3 days). Patients receiving either oral (prednisone 2 mg/kg (maximum 80 mg)) or intravenous corticosteroids (methylprednisolone 2 mg/kg (maximum 80 mg)) and discharged home received a 4-day course of the oral preparation (prednisone 1 mg/kg/day BID (maximum 40 mg/day)). Of 135 children enrolled, 106 were discharged, 26 were hospitalized, and 3 were disqualified. There were significantly less hospitalizations and unscheduled return visits in the inhaled (7% hospitalized, 12% unscheduled return visits) as compared to the oral (22%, 42%) and intravenous (29%, 41%) groups (p=0.02, p=0.007). In children with a moderate-to-severe asthma exacerbation, inhaled triamcinalone reduced the rate of hospitalizations when compared to oral prednisone and intravenous methyl-prednisolone. In the week after discharge from the emergency center, children continuing inhaled triamcinalone had fewer unscheduled return visits than children continuing oral prednisone.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010846154

Download citation: RISBibTeXText

DOI: 10.1089/088318703322247598


Related references

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 60(9): 730-734, 2005

Asthma diagnosis and treatment - 1018. Effect of inhaled corticosteroids with long-acting beta2 agonists vs. inhaled corticosteroids alone on asthma control in children: results from national ashtma survey. World Allergy Organization Journal 6 Suppl 1: P18, 2013

Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma. Respiratory Medicine 103(4): 614-620, 2008

Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatric Pulmonology 49(4): 326-334, 2014

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma. Pulmonary Pharmacology and Therapeutics 16(5): 299-306, 2003

Chronic inhaled corticosteroids do not affect the course of acute severe asthma exacerbations in children. Pediatric Pulmonology 41(12): 1213-1217, 2006

Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2010(5): Cd005535, 2010

Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Annals of Emergency Medicine 60(1): 84-91.E3, 2012

Cost-utility of inhaled corticosteroids in patients with moderate-to-severe asthma. Expert Review of Pharmacoeconomics and Outcomes Research 4(5): 549-564, 2004

Combination of inhaled corticosteroids plus other medications in the management of moderate to severe persistent asthma. Allergy and Asthma Proceedings 21(5): 315-322, 2000

Local adverse effects associated with the use of inhaled corticosteroids in patients with moderate or severe asthma. Jornal Brasileiro de Pneumologia 39(4): 409-417, 2014

Rhumab-E25 treatment allows sustained reduction of the need for inhaled corticosteroids in moderate/severe allergic asthma. Journal of Allergy & Clinical Immunology 107(2): S106-S107, 2001

Combination regimens of the inhaled preparation ie; salbutamol with corticosteroids proved more effective in relieving severe bronchial asthma than high doses of corticosteroids alone. Chest 118(4 Suppl ): 189S, 2000

Replacement of Oral Corticosteroids With Inhaled Corticosteroids in the Treatment of Acute Asthma Following Emergency Department Discharge. Chest Journal 121(6): 1798-1805, 2002

Exhaled nitric oxide levels are associated with daily lung function declines and increased medication usage in urban children with moderate to severe asthma despite use of inhaled corticosteroids and long-acting bronchodilators. Journal of Allergy and Clinical Immunology 119(1-supp-S), 2007